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Dengue Virus (DenV) is an arbovirus that represents a 
budding risk in the world. Every year, up to 100 million 
DenV infections manifest into Dengue Fever or in 
extreme cases Dengue Hemorrhagic Fever and Dengue 
Shock Syndrome. DenV research in vaccine 
development has proven to be a difficult feat due to the 
phenomenon of antibody dependent enhancement. 
Furthermore, there are currently no available antivirals to 
fight infection, viral protein processing or viral 
production. DenV lifecycle begins with its genomic 
release in the cytoplasm, where it is then translated as a 
single polypeptide embedded in the Endoplasmic 
Reticulum (ER) membrane. DenV, like so many other 
viruses, exploits a range of host enzymes in the Classical 
Secretory Pathway (CSP) for modifications. Among 
these important host enzymes are proteases such as the 
family of Proprotein Convertases (PCs), including furin. 
The modulation of the pre- membrane (pr-M) protein, 
most likely by PCs, is a critical step in the DenV 
lifecycle as an absence results in noninfectious progeny. 
Interestingly, the maturation of pr-M by the host 
enzymes during infection has been characterized as 
incomplete, thus rendering some viral particles 
noninfectious. Thus, the inhibition of pr-M cleavage 
presents an attractive target for potential antivirals. This 
assay is based on a fusion that contains an ER targeting 
signal sequence, the substrate of significance with 
flanking FLAG and HA epitopes, and a transmembrane 
(TM) domain. The assay in the context of the pr-M 
boundary has shown robust transportation with a wild 
phenotype in both transient and stable cell expression 
using retroviral technology. The original pr-M substrate 
included only 20 aa of the substrate boundary. Here, I 
have designed different substrate boundaries of pr-M to 
monitor important motifs in enzyme recognition and 
secretion, hypothesizing that by adapting to larger 
segments, we will have a powerful platform for the 
discovery of competitive inhibitors rather than inhibitors 
of the enzyme. 
 
Keywords: Dengue Virus (DenV), Proprotein 
Convertases (PCs), Classical Secretory Pathway 
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INTRODUCTION 
DenV is a Flavivirus of the Flaviviridae 
family, which also encompasses other prominent 
public health concerns as Japanese Encephalitis 
Virus, Yellow Fever Virus, West Nile Virus, and 
more recently Zika Virus, amongst others. DenV, 
which causes greater rates of mortality and disease 
than other members of Flavivirus genus, is 
comprised of four distinct serotypes (DenV-1 to -
4), although a fifth non-human infecting serotype 
has been up for debate as of recently 
(Mukhopadyay et al., 2005). DenV is an arbovirus, 
transmitted primarily through the Aedes aegypti 
mosquitos and to a lesser extent Aedes albopictus 
(Gyawali et al., 2016). Although, there are several 
transmission cycles i.e. forest/enzootic, 
rural/epidemic, the most important as a public 
health concern is the urban/endemic/epidemic cycle 
(Gyawali et al., 2016). It seems that A. aegypti are 
ideal vectors for urbanization, as they are highly 
domesticated, prefer laying eggs in artificial 
containers easily found around homes, and are 
known to be nervous feeders that will disrupt a 
blood meal at the slightest movement and at times 
continue their meal on a different person (Gyawali 
et al., 2016). 
Unsurprisingly, DenV is predominantly endemic to 
tropics and sub-tropics in correspondence with the 
Aedes mosquito distribution, however, it has 
disseminated from these regions as of late due to 
increased world travel and migration of its vectors. 
DenV has a long history worldwide, as descriptions 
of possible DenV caused disease date back as early 
as the Chin dynasty in 265-420 A.D., while 
potential outbreaks in the West Indies, Panama, 
Indonesia, and Cairo occurred in subsequent years 
and its rather likely to be the causative pathogen 
behind an epidemic in Philadelphia in 1780 (Gubler 
and Kuno, 1998). Up until World War II there were 
infrequent outbreaks, although, DenV was likely 
endemic to urbanized tropical regions as cases 
fitting DenV description were often seen in 
nonimmune visitors within a short period of arrival. 
The ecological havoc that occurred during and 
post-World War II in parts of Southeast Asia and 
the Pacific, has been linked to an increase in 
mosquito-borne disease, and in turn, setting the 
table for the global pandemic of DenV. In the past 
50 years, alarmingly, there has been a 30-fold 
increase in the incidence of DenV. The exponential 
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growth of the world population along with poorly 
planned urbanization policies have contributed 
greatly to the rise in DenV prevalence, although 
factors such as ineffective mosquito control in 
endemic areas as well increased globalization 
surely play a role as well. Furthermore, the 
development of multiple cocirculating serotypes 
otherwise known as hyperendemicity has struck 
centers around the world (Figure 1). 
 
Figure 1. Shows the global distribution of DenV serotypes 1-4 over the past three decades. 
 
It has been estimated that 2.5 billion 
people are at risk of DenV infection and that 390 
million people are infected yearly (Gyawali et al., 
2016). Upon transmission, DenV has an incubation 
time of between 2 and 14 days which can culminate 
to a mild self-limiting case of DenV fever with 
symptoms that include; abdominal and muscle 
pain, persisting nausea and vomiting, bleeding of 
mucosal membranes, lethargy, and decreased 
platelet count. Primary infections are typically not 
life-threatening and viral clearance results in life-
long immunity to the specific serotype. Subsequent 
infection with a heterotypic virus, however, can 
end in an immunological phenomenon called 
antibody-dependent enhancement (ADE), which is 
associated with severe forms of DenV known as 
Dengue Hemorrhagic Fever (DHF) and Dengue 
Shock Syndrome (DSS), in which patients 
experience severe plasma leakage, severe bleeding, 
and organ failure. ADE is still yet to be completely 
characterized, although it’s been shown that 
antibodies from previous infections can react with 
DenV particles at sub neutralizing levels and 
facilitate increased uptake by host cells. ADE is 
further associated with cytokine cascades (Boonnak 
et al., 2008; Suwanmanee and Luplertlop, 2017). 
To date, there are no FDA approved 
antiviral therapies to combat DenV infection. 
Similarly, licensed vaccine development has been 
hindered by the seemingly insurmountable cross-
reactivity associated with ADE. Although, recently 
there has been optimism with vaccines used in 
countries in Latin America and Southeast Asia 
there is a growing concern of its viability as DenV 
antibodies seem to cross-react with the closely 
related Zika Virus, potentially enhancing its 
infectivity as well (Aguiar et al., 2016; Bardina et 
al., 2017). For these reasons, treatment for DenV 
has been primarily through palliative care. In 
conjunction with vaccine development, there has 
been a heavy emphasis on vector control to 
decrease the spread. Efforts have been realized 
through insecticides, educating the public, and 
more recently the release of genetically engineered 
male mosquitos that pass on lethal genes to their 
progeny. Insecticide resistant mosquitos have 
already been documented and the unknown 
efficacy of these genetically modified mosquitos, 
as well as the wide distrust of the public in GMOs 
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illustrate some of the pitfalls of current vector 
control tactics. 
MATERIALS AND METHODS 
Cell maintenance: 
The human T-cell line SupT1 was 
obtained from the American Type Culture 
Collection (ATCC, Manassas, VA) and cells were 
maintained in complete RPMI 1640 media 
supplemented with 10% fetal bovine serum 
(Gemini Bio-Products, West Sacramento, CA), 
glutamine (2mM), penicillin G (100units/mL), and 
streptomycin (100μg/mL). Phoenix GP, BHK-21, 
and HEK 293T cell-lines (Nolan Lab, Stanford 
University, CA) were maintained in Dulbecco’s 
Modified Eagle’s media (DMEM) supplemented 
with 10% fetal bovine serum (Gemini Bio-
Products, West Sacramento, CA), glutamine 
(2mM), penicillin G (100 units/mL), and 
streptomycin (100 μg/mL). 
Transfection experiments for transient expression 
For transient expression experiments 1.5 x 
105 HEK 293T or BHK-21 cells were plated in a 
12- well plate 24 hours prior to transfection. 1μg of 
DNA was mixed in 100μL serum-free DMEM, 
while 8μL Polyethylenimine (PEI) Max (linear, 
MW 25000; 
Polysciences, Inc, Warrington, PA) was incubated 
in a separate 100μL of serum-free DMEM. After 7 
minutes of incubation, the two mixtures were 
combined and incubated together for 12 minutes at 
room temperature. The mixture was then added 
dropwise to each well and analyzed 48 hours post-
transfection through Western and FACS based 
techniques. 
Antibodies and reagents 
Anti-FLAG antibody was obtained from Sigma 
Aldrich (St. Louis , MO). Anti-HA, anti-PDI, anti-
mouse IgG Alexa Fluor 488, anti-rabbit IgG Alexa 
Fluor 647, anti-mouse IgG HRP-conjugated, and 
anti-rabbit IgG HRP-conjugated antibodies were 
obtained from Cell Signaling (Beverly, MA). 
Wheat Germ Agglutinin (WGA) Alexa Fluor 555 
conjugate stain was generously donated from Dr. 
Sussman (Sussman Lab, San Diego State 
University, CA). 
Confocal microscopy 
For confocal microscopy experiments, 
cover slips were prepared in a 24-well plate by first 
sterilizing the slips in 95% Ethanol, washing them 
once with phosphate buffer saline (PBS), then 
treating them with 200μL of 0.1% gelatin in PBS 
for 30 minutes at 37° C. After 30 minutes the 
excess gelatin was removed from each well and the 
plate was allowed to dry for 1-2 hours at room 
temperature. 1.0 x 105 HEK 293T cells or 7.0 x 
104 BHK-21 cells were then plated to each well 
and allowed to incubate for 24 hours before being 
transfected using the protocol listed above. 48 
hours post-transfection cells were washed once 
with PBS and fixed using either 2% or 4% 
formaldehyde at room temperature for 20 minutes. 
Cells were then washed with a blocking buffer 
(PBS, 1% BSA, 0.1% Triton-X) and appropriate 
wells were permeabilized with 100% methanol for 
10 minutes. Following permeabilization cells were 
washed with blocking buffer, and then blocked for 
one hour at room temperature using blocking 
buffer. Following blocking step, cells were stained 
with primary antibody according to manufacturer’s 
usage dilution overnight at 4° C. The next day cells 
were washed three times with PBS and incubated 
with a fluorescently conjugated secondary antibody 
at a final dilution of 1:500 for 1-2 hours at room 
temperature in the dark. Cells were then washed 
three times with PBS and appropriately stained 
with DAPI, for nuclear staining, at 1:5000 dilution 
and/or with wheat germ agglutinin (WGA) at 1:200 
dilution. Slides were then prepared by washing 
cells once with PBS then removing cover slips 
from the wells and mounting on a microscope slide 
using ProLong Diamond Antifade Mountant (Life 
Technologies, Eugene, Or) and allowed to dry 
overnight. Slides were then analyzed using the 
Zeiss 710 Confocal Microscope and data was 
collected using ZEN digital imaging software. 
Flow cytometry 
Cells were collected, pelleted, and 
incubated with mouse anti-FLAG (Sigma Aldrich, 
St. Louis, MO) and rabbit anti-HA (Cell Signaling, 
Beverly, MA) antibodies at a 1:400 dilution for 30 
minutes. Cells were then washed with PBS and 
incubated with anti-mouse IgG Alexa Fluor 488 
and anti-rabbit IgG Alexa Fluor 647 antibodies 
(Cell Signaling, Beverly, MA) at a 1:400 dilution 
for 30 minutes in the dark and then washed with 
PBS. Flow cytometry analysis was performed using 
a BD FACSCanto with 488nm and 633nm lasers 
and data collection was done using FACSDiva 
6.1.1 and analyzed using FlowJo 7.6.1. 
Western blot 
HEK 293T or BHK-21 cells were collected and 
pelleted and then washed with PBS before being 
incubated with 100μL modified 
Radioimmunoprecipitation assay (RIPA) buffer 
with the serine protease cocktail phenylmethane 
sulfonyl fluoride (PMSF) for 30 minutes on ice. 
Then 4x Laemmli buffer with 5% beta-
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mercaptoethanol (BME) was added to each lysate 
and samples were boiled at 100 C for 5 minutes. 
Next, the samples were loaded onto 12-15% SDS-
PAGE Tris-Glycine gels and run at 60mA for 
approximately 1 hour. Proteins were then 
transferred to a polyvinylidene fluoride (PVDF) 
membrane (Genesee Scientific Corporation, San 
Diego, CA) at 350mA for 1 hour . The membranes 
were then blocked using 5% milk (Saco Foods, 
Middleton, WI) in TBST for 1-2 hours at room 
temperature. Following blocking, membranes were 
incubated in a 5% milk mixture with rabbit anti-
HA primary antibody (Santa Cruz Biotechnology, 
Dallas, TX) at 1:2000 dilution and/or mouse anti-
actin primary antibody (Cell Signaling, Beverly, 
Ma) overnight at 4° C. The following day 
membranes were washed three times with TBST. 
Next, membranes were incubated with either anti-
rabbit or anti-mouse HRP conjugated secondary 
antibodies (Cell Signaling, Beverly, Ma) at 1:4000 
dilution in 5% milk for 1-2 hours at room 
temperature. The membranes were then again 
washed three times with TBST. Protein detection 
was done using the ECL Start Western Blotting 
Detection Reagents (GE Healthcare, 
Buckinghamshire, UK) and Blue Devil  
 
Figure 2. Flow cytometry analysis of SupT1 cell lines.  
 
Adaptation of the assay to larger portions of Denv 
pr-m 
It was previously mentioned, that 20 aa of 
the DenV pr-M cleavage boundary in the context of 
the assay shows a robust detection of cleaved 
product on the cell surface, which was believed to 
mimic the natural processing en route of secretion. 
Interestingly, however, when barcoded cell lines 
that express either the original short boundary of 
HIV Env or short DenV pr-M are multiplexed and 
treated with a pan-PC inhibitor, known as 
decanoyl-RVKR- chloromethyl ketone (DCK) 
(Molloy et al., 1994), HIV Env cleavage is 
blocked, while DenV pr-M processing remains 
active (Figure 2). These results indicate several 
possibilities; 1) DenV pr-M is not cleaved by 
members of the PC family or not only by PCs, 2) 
DCK is not completely active against all PCs, 3) 20 
aa boundary of DenV pr-M does not accurately 
represent the natural folding and therefore it’s 
exposed to proteases that normally would not be 
recognizing it. To address these concerns, larger 
segments of DenV pr-M were designed to replace 
the original border to make it more biologically 
robust. 
The first step in adapting larger pieces to 
the original assay was to determine which regions 
of pr-M to include in order to make a functional 
assay that mimics the natural peptide as thoroughly 
as possible. The first interest was to find and delete 
transmembrane domains that could impair the 
functionality of the assay by preventing transport 
through the CSP or by altering the topology in such 
a way that the substrate is exposed to the 
cytoplasm. Truncations were thus designed to that 
contained the full length pr- portion and C’ 
terminal truncations that would exclude 
transmembrane domains, as well as regions such as 
the stem that interact with the membrane. 
Additionally, N’ terminal truncations of pr- were 
designed to elucidate necessary residues for proper 
transport and cleavage. In addition to the published 
glycosylated residue N69, the glycosylation 
predictor software, GlycoEP, was used to search 
for potentially modified residues that might affect 
processing of pr-M  (Perera and Kuhn, 2008; 
Chauhan et al., 2013). These truncations also serve 
to delete cysteine residues that are conserved 
amongst members of Flaviviridae that probably 
form C-C disulfide bonds (Nowak and Wengler, 
1987).  
Replacement with viral transmembrane domains 
The original DenV pr-M short construct, 
as well as the larger pieces mentioned thus far, 
were designed to mimic the natural process of 
maturation in DenV infection. Up to this point, 
however, maturation and transport has relied on an 
artificial transmembrane domain (Lyt2). Since 
there is a strong possibility that the transmembrane 
domain of M plays a role in both processing and 
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transport, the Lyt2 domain was replaced with the 
transmembrane containing C’ terminal 67 aa of M. 
Additionally, pr-serves an intrinsic role during viral 
infection by chaperoning and shielding the fusion 
loop of E to prevent its fusion with inappropriate 
membranes. The interaction between pr-M with E 
is also critical for exposing the furin recognition 
site during the pH induced conformational change 
of the TGN (Zhang et al., 2012). Flow cytometry 
analysis of transiently expressed pr-M C67M and 
pr-M C67E shows a lack of transport to the cell 
surface (data not shown). 
Western blot analysis with and without lyt2 
Transfection experiments failed to show 
surface expression of DenV pr-M C67M and DenV 
pr-M C67E through flow cytometry. Thus, BHK-
21 cells were transfected with eGFP, DenV pr-M 
short, DenV pr-M short mutant, DenV pr-M 
∆C’67, DenV pr-M ∆C’67 mutant, DenV pr-M 
C67M, and DenV pr-M C67E for Western blot. 
Cells were collected two days’ post transfection 
and probed using anti-HA and anti-Actin. Cleavage 
of the pr-M boundary was not detected in any of 
the constructs, however, cells that express DenV 
pr-M C67E shows cleavage between pr-M and E 
by signal peptidase, which should occur prior to pr-
M processing. 
 
Confocal microscopy for surface expression 
Confocal microscopy was performed to corroborate 
that DenV pr-M constructs were being expressed 
and targeted to the right compartment. In short, 
BHK-21 cells were transfected and stained two 
days later. The surface marker stain Wheat Germ 
Agglutinin (WGA) and anti-HA were used in the 
absence of cell permeabilization, to probe for 
transportation of the scaffold of DenV pr-M short, 
DenV pr-M ∆C’67, DenV pr-M C67M, and DenV 
pr-M C67E. Surface expression was detected for 
DenV pr-M short and DenV pr- M ∆C’67 wild 
types and mutants, but not for DenV pr-M C67M 
or DenV pr-M C67E (Figure 3). A subsequent 
confocal experiment was performed in which cells 
were permeabilized using 100% methanol, and 
antibodies against HA and Protein Disulfide 
Isomerase (PDI), an ER marker, transfected with 
the same constructs (Figure 3). The microscopy 
shows that the constructs are being targeted to the 
ER, as seen in the merge. Interestingly, there seems 
to be a lower amount of co-localization between 
HA and PDI in the short constructs when compared 
to the DenV pr-M ∆C’67, DenV pr-M C67M, and 
DenV pr-M C67E, which might indicate that the 
short versions are being autoradiography film 
(Genesee Scientific Corporation, San Diego, 
CA).efficiently shuttled to the cell surface, while 
the remainder are transported less efficiently or 
being retained in the ER. 
 
Figure 3. Western blot analysis shows expression of DenV pr-M constructs with natural transmembrane 
domains of M, as well as the Lyt2 containing constructs.   
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Figure 4. Confocal microscopy of DenV pr-M constructs treated with 2% paraformaldehyde and stained using 
anti-HA, WGA, and DAPI.  
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Figure 5. Confocal microscopy of DenV pr-M constructs permeabilized and stained using anti-HA, anti-PDI, 
and DAPI. 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
Adaptation of the assay to larger DenV pr-
M segment allows us to utilize it as a platform to 
screen chemical libraries for compounds that 
disrupt the proteolytic activity of furin or other 
furin-like PCs. The larger substrate should aid the 
search for competitors of furin cleavage rather than 
direct inhibitors of the enzyme, ensuring that 
enzyme activity itself is not interrupted. Because 
surface expression of DenV pr-M ∆C’67 shows a 
cleaved signal, it could thus be utilized to probe for 
disruption of enzymatic activity through the 
reconstitution of FLAG. 
DenV pr-M ∆C’67 will be further 
developed as a cellular platform for high 
throughput screening (HTS) using retroviral 
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technologies and non-adherent cell lines such as 
SupT1s or U937 macrophages. FACS based cell 
sorting will be exploited to develop homogenous 
clones and used in preliminary screens exploiting 
our available Prestwick and TPIMS combinatorial 
chemical libraries. Our lab has shown continued 
success in generating stably expressing cell-lines 
for use of targeted drug discovery in preliminary 
screens (Stolp et al., 2015). 
While the cell lines are being established 
for serotype-2 of DenV pr-M, we will further adapt 
the large and small functional pieces to serotypes-
1, -3, and -4 of DenV. Our lab has demonstrated 
the efficiency and specificity of our cell-based 
assays used in a multiplexed format. Multiplexing 
allows researcher to rapidly analyze a series of 
targets simultaneously (Stolp et al., 2015). 
Smurthwaite et al previously proved that 
fluorescent proteins of different intensities could be 
used to accurately distinguish between clonal cell 
populations when mixed in the same sample 
(Smurthwaite, 2013). Utilizing fluorescently 
barcoded cell lines, the authors were able screen 
several mutant HIV proteases to inhibitors in the 
same sample and saw distinct populations that each 
behaved in accordance to literature (Smurthwaite, 
2013). Therefore, cells harboring the small and 
large DenV pr-M assay for serotypes-1 through -4 
can be genetically barcoded with different 
fluorescent markers in order to maximize screening 
potential and streamline the process of a pan-
serotypic inhibitor. This will allow the screening of 
multiple DenV pr-M substrates simultaneously 
with internal controls for specificity of inhibitors. 
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